Saturday, 21 November 2026
M
Meridian Globe
Live briefing
[Editorial] Multiple sclerosis: beyond controlling relapses— 柳叶刀 Lancet[Comment] Remibrutinib: a high-efficacy disease-modifying drug for relapsing multiple sclerosis?— 柳叶刀 Lancet[Comment] Expanding the post-EGFR TKI landscape with antibody–drug conjugates— 柳叶刀 Lancet[Comment] Sacituzumab tirumotecan in previously treated endometrial cancer— 柳叶刀 Lancet[Comment] Retraction: Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother— 柳叶刀 Lancet[Comment] Offline: A manifesto for protecting public health— 柳叶刀 Lancet[World Report] Türkiye's coal industry draws criticism— 柳叶刀 Lancet[World Report] Research Focus: Te Poutoko Ora a Kiwa (Centre for Pacific and Global Health)— 柳叶刀 Lancet[Editorial] Multiple sclerosis: beyond controlling relapses— 柳叶刀 Lancet[Comment] Remibrutinib: a high-efficacy disease-modifying drug for relapsing multiple sclerosis?— 柳叶刀 Lancet[Comment] Expanding the post-EGFR TKI landscape with antibody–drug conjugates— 柳叶刀 Lancet[Comment] Sacituzumab tirumotecan in previously treated endometrial cancer— 柳叶刀 Lancet[Comment] Retraction: Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother— 柳叶刀 Lancet[Comment] Offline: A manifesto for protecting public health— 柳叶刀 Lancet[World Report] Türkiye's coal industry draws criticism— 柳叶刀 Lancet[World Report] Research Focus: Te Poutoko Ora a Kiwa (Centre for Pacific and Global Health)— 柳叶刀 Lancet

Turkey Asks Hundreds to Return Gains From Fund Crisis

Source Bloomberg 财经8h ago
Summary

A Turkish state body demanded voluntary repayments from the hundreds of individuals and corporations that made the largest profits from a fund scandal that’s r…

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Business
Region
Americas
Language
English
Item ID
business-e7e9caa9

Comments 0 comments

No comments yet. Be the first.

Turkey Asks Hundreds to Return Gains From Fund Crisis · Meridian Globe